TREA

97977591 - ENTOS

Follow

Information

  • Trademark
  • 97977591
  • Serial Number
    97977591
  • Registration Number
    7446491
  • Filing Date
    September 14, 2022
    3 years ago
  • Registration Date
    July 16, 2024
    a year ago
  • Transaction Date
    January 08, 2025
    9 months ago
  • Status Date
    July 16, 2024
    a year ago
  • Published for Opposition Date
    April 30, 2024
    a year ago
  • Location Date
    July 15, 2024
    a year ago
  • First Use Anywhere Date
    April 01, 2011
    14 years ago
  • First Use In Commerce Date
    January 23, 2018
    7 years ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    HENRY, NAKIA
  • Attorney Docket Number
    079440.00016
    Attorney Name
    Theodore R. Remaklus
  • Owners
Information
Mark Drawing Code
4
Mark Identification
ENTOS
Case File Statements
  • GS0401: Custom manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies for others; custom manufacturing of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies
  • TR0010: The English translation of the word "Entos" in the mark is "within".
  • GS0441: Medical therapy services, namely, gene therapy services; medical analysis services, namely, RNA or DNA analysis for virus diagnosis and prognosis; medical information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; on-line information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; genetic testing for medical purposes
  • GS0421: Advisory services relating to gene therapy research; research in the field of gene therapy; research and development of vaccines and medicines; information on the subject of scientific research in the field of biotechnology; genetic testing for scientific research purposes; scientific research in the field of genetics and genetic engineering; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the field of therapeutic and diagnostic products; scientific research, pharmaceutical research, medical research, technical consultation in the field of pharmaceutical studies and product development for others in the field of biotechnology and product development of pharmaceuticals, therapeutic agents and medical devices; research and product development in the field of human vaccines, recombinant proteins and antibodies for therapeutic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates
Case File Event Statements
  • 6/27/2023 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/17/2022 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/29/2022 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/26/2023 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/27/2023 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/27/2023 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/27/2023 - 2 years ago
    7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 9/27/2023 - 2 years ago
    8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 11/16/2023 - a year ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/16/2023 - a year ago
    14 - DIVISIONAL REQUEST RECEIVED Type: DRRR
  • 11/16/2023 - a year ago
    9 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD
  • 11/16/2023 - a year ago
    10 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 11/16/2023 - a year ago
    11 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 3/6/2024 - a year ago
    13 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 3/8/2024 - a year ago
    15 - DIVISIONAL PROCESSING COMPLETE Type: DPCC
  • 3/11/2024 - a year ago
    16 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/11/2024 - a year ago
    17 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 3/11/2024 - a year ago
    18 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 3/11/2024 - a year ago
    19 - ASSIGNED TO LIE Type: ALIE
  • 3/12/2024 - a year ago
    20 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 3/22/2024 - a year ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/10/2024 - a year ago
    22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/30/2024 - a year ago
    23 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/30/2024 - a year ago
    24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/16/2024 - a year ago
    25 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/4/2025 - 10 months ago
    32 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/4/2025 - 10 months ago
    33 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF
  • 1/4/2025 - 10 months ago
    30 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 1/4/2025 - 10 months ago
    29 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 1/4/2025 - 10 months ago
    31 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/4/2025 - 10 months ago
    28 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 7/16/2024 - a year ago
    26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/16/2024 - a year ago
    27 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC